New Zealand vs Puerto Rico: Treatment success rate for patients treated for MDR-TB
New Zealand
100.0%
in 2022
Puerto Rico
100.0%
in 2020
New Zealand rank
1st
Puerto Rico rank
1st
Treatment success rate for patients treated for MDR-TB over time
- New Zealand
- Puerto Rico
How they compare
New Zealand currently reports 100.0% against 100.0% in Puerto Rico, a difference of 0.0%.
The two have swapped places 3 times across 7 shared years of data; in 2007 it was New Zealand ahead.
New Zealand ranks 1st and Puerto Rico ranks 1st of 163 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | New Zealand | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 0.0% | 50.0% | New Zealand |
| 2010s | 75.0% | 73.4% | 1.6% | New Zealand |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, New Zealand or Puerto Rico?
- New Zealand, at 100.0% against 100.0% in Puerto Rico as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between New Zealand and Puerto Rico?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Puerto Rico?
- 7 years are reported by both, from 2007 to 2020.
- How do New Zealand and Puerto Rico rank globally for treatment success rate for patients treated for mdr-tb?
- New Zealand ranks 1st and Puerto Rico ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.